Cushman & Wakefield (NYSE:CWK – Get Free Report) is anticipated to issue its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect the company to announce earnings of $0.3577 per share and revenue of $2.78 billion for the quarter. Investors can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 9:00 AM ET.
Cushman & Wakefield (NYSE:CWK – Get Free Report) last released its earnings results on Tuesday, June 30th. The company reported $0.35 EPS for the quarter. Cushman & Wakefield had a net margin of 0.64% and a return on equity of 15.90%. The company had revenue of $2.76 billion for the quarter. On average, analysts expect Cushman & Wakefield to post $1.45 EPS for the current fiscal year and $1.63 EPS for the next fiscal year.
Cushman & Wakefield Price Performance
CWK opened at $13.29 on Monday. Cushman & Wakefield has a 1 year low of $10.88 and a 1 year high of $17.40. The firm has a market capitalization of $3.12 billion, a PE ratio of 45.84 and a beta of 1.52. The business’s 50-day moving average is $12.55 and its two-hundred day moving average is $13.41. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.08 and a quick ratio of 1.08.
Analyst Ratings Changes
CWK has been the subject of several recent analyst reports. Zacks Research lowered shares of Cushman & Wakefield from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. Morgan Stanley lowered their target price on shares of Cushman & Wakefield from $19.00 to $15.00 and set an “overweight” rating for the company in a report on Thursday, October 22nd. Citizens Jmp dropped their price objective on shares of Cushman & Wakefield from $19.00 to $16.00 and set a “market outperform” rating for the company in a research note on Thursday, October 22nd. Weiss Ratings raised Cushman & Wakefield from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Finally, Barclays upped their price target on shares of Cushman & Wakefield from $15.00 to $16.00 and gave the stock an “equal weight” rating in a research note on Monday, August 17th. Five equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.57.
Read Our Latest Research Report on CWK
Insider Buying and Selling
In related news, insider Laurida Sayed sold 16,000 shares of the business’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $13.88, for a total value of $222,080.00. Following the sale, the insider owned 5,461 shares of the company’s stock, valued at $75,798.68. The trade was a 74.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Nathaniel Robinson sold 12,500 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $13.39, for a total value of $167,375.00. Following the transaction, the insider directly owned 58,376 shares in the company, valued at $781,654.64. The trade was a 17.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.74% of the stock is currently owned by corporate insiders.
Cushman & Wakefield Company Profile
Cushman & Wakefield plc (NYSE: CWK) is a global commercial real estate services company that provides advisory, transaction, and property-related solutions to property owners, occupiers, investors, and developers. The company serves clients across office, industrial, retail, multifamily, hospitality, and other real estate sectors.
Its services include leasing and tenant representation, capital markets and investment sales, valuation and advisory, property and facilities management, project and development services, and workplace and portfolio consulting.
Featured Stories
- Five stocks we like better than Cushman & Wakefield
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter.
